Lazard Asset Management’s Voyager Therapeutics VYGR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-148
| Closed | – | – | 2598 |
|
|
2024
Q4 | $0 | Sell |
148
-6,337
| -98% | – | ﹤0.01% | 2559 |
|
|
2024
Q3 | $37K | Buy |
6,485
+6,082
| +1,509% | +$34.7K | ﹤0.01% | 1958 |
|
|
2024
Q2 | $3K | Sell |
403
-18,339
| -98% | -$137K | ﹤0.01% | 2095 |
|
|
2024
Q1 | $174K | Buy |
18,742
+9,146
| +95% | +$84.9K | ﹤0.01% | 1350 |
|
|
2023
Q4 | $80K | Sell |
9,596
-13,429
| -58% | -$112K | ﹤0.01% | 1751 |
|
|
2023
Q3 | $178K | Buy |
23,025
+899
| +4% | +$6.95K | ﹤0.01% | 1428 |
|
|
2023
Q2 | $253K | Buy |
22,126
+10,260
| +86% | +$117K | ﹤0.01% | 1282 |
|
|
2023
Q1 | $91K | Buy |
11,866
+3,775
| +47% | +$29K | ﹤0.01% | 1569 |
|
|
2022
Q4 | $49K | Sell |
8,091
-2,192
| -21% | -$13.3K | ﹤0.01% | 1826 |
|
|
2022
Q3 | $60K | Hold |
10,283
| – | – | ﹤0.01% | 1716 |
|
|
2022
Q2 | $60K | Sell |
10,283
-7,395
| -42% | -$43.1K | ﹤0.01% | 1733 |
|
|
2022
Q1 | $134K | Buy |
17,678
+10,455
| +145% | +$79.2K | ﹤0.01% | 1330 |
|
|
2021
Q4 | $19K | Buy |
7,223
+1,253
| +21% | +$3.3K | ﹤0.01% | 2058 |
|
|
2021
Q3 | $15K | Sell |
5,970
-2,970
| -33% | -$7.46K | ﹤0.01% | 2055 |
|
|
2021
Q2 | $36K | Buy |
8,940
+8,762
| +4,922% | +$35.3K | ﹤0.01% | 1726 |
|
|
2021
Q1 | $0 | Sell |
178
-11,924
| -99% | – | ﹤0.01% | 2047 |
|
|
2020
Q4 | $86K | Buy |
+12,102
| New | +$86K | ﹤0.01% | 1220 |
|
|
2019
Q4 | – | Sell |
-913
| Closed | -$15K | – | 1677 |
|
|
2019
Q3 | $15K | Buy |
+913
| New | +$15K | ﹤0.01% | 1163 |
|
|
2018
Q2 | – | Sell |
-25,658
| Closed | -$482K | – | 1123 |
|
|
2018
Q1 | $482K | Buy |
25,658
+5,479
| +27% | +$103K | ﹤0.01% | 779 |
|
|
2017
Q4 | $334K | Buy |
+20,179
| New | +$334K | ﹤0.01% | 822 |
|